160 related articles for article (PubMed ID: 16969674)
21. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.
Cox L; Calderón M; Pfaar O
Immunotherapy; 2012 Jun; 4(6):601-16. PubMed ID: 22788128
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.
Nelson HS; Nolte H; Creticos P; Maloney J; Wu J; Bernstein DI
J Allergy Clin Immunol; 2011 Jan; 127(1):72-80, 80.e1-2. PubMed ID: 21211643
[TBL] [Abstract][Full Text] [Related]
23. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
[TBL] [Abstract][Full Text] [Related]
24. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
Martín JP
Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950
[No Abstract] [Full Text] [Related]
25. Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective.
Bachert C; Vestenbaek U; Christensen J; Griffiths UK; Poulsen PB
Clin Exp Allergy; 2007 May; 37(5):772-9. PubMed ID: 17456225
[TBL] [Abstract][Full Text] [Related]
26. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
27. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
Buczyłko K; van der Werf JF; Boot D; van Ree R
Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
[TBL] [Abstract][Full Text] [Related]
28. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
29. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
Werfel T
J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
[No Abstract] [Full Text] [Related]
30. Accelerated immunotherapy schedules and premedication.
Calabria CW; Cox L
Immunol Allergy Clin North Am; 2011 May; 31(2):251-63, ix. PubMed ID: 21530818
[TBL] [Abstract][Full Text] [Related]
31. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
[TBL] [Abstract][Full Text] [Related]
33. GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma.
Zuberbier T; Bachert C; Bousquet PJ; Passalacqua G; Walter Canonica G; Merk H; Worm M; Wahn U; Bousquet J
Allergy; 2010 Dec; 65(12):1525-30. PubMed ID: 21039596
[TBL] [Abstract][Full Text] [Related]
34. Cluster protocols in SCIT: enough evidence for practical use?
Pfaar O; Leitzbach S; Hörmann K; Klimek L
Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):188-93. PubMed ID: 20410818
[TBL] [Abstract][Full Text] [Related]
35. Accelerated immunotherapy schedules.
Calabria CW
Curr Allergy Asthma Rep; 2013 Aug; 13(4):389-98. PubMed ID: 23728613
[TBL] [Abstract][Full Text] [Related]
36. Kinetics and dynamic evaluation of specific immunotherapy.
Pereira C; Botelho F; Tavares B; Lourenço C; Baeta C; Palma-Carlos AG; Lima J; Chieira C
Eur Ann Allergy Clin Immunol; 2004 Dec; 36(10):375-86. PubMed ID: 15662966
[TBL] [Abstract][Full Text] [Related]
37. [Cluster immunotherapy in allergic rhinoconjunctivitis].
Klimek L; Pfaar O
MMW Fortschr Med; 2011 Feb; 153(7):34-6. PubMed ID: 21648138
[No Abstract] [Full Text] [Related]
38. Subcutaneous immunotherapy in Northern Israel: efficacy and safety.
Rottem M; Egbarya A
Isr Med Assoc J; 2014 Sep; 16(9):539-43. PubMed ID: 25351009
[TBL] [Abstract][Full Text] [Related]
39. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
Nelson H; Lehmann L; Blaiss MS
Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
[TBL] [Abstract][Full Text] [Related]
40. [Allergen specific immunotherapy: new approaches].
Tay F; Kündig TM; Senti G
Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
